이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Cogstate 관리
관리 기준 확인 3/4
Cogstate's CEO는 Brad O'Connor, Dec2005 에 임명되었습니다 의 임기는 18.5 년입니다. 총 연간 보상은 $ 1.10M, 33.1% 로 구성됩니다. 33.1% 급여 및 66.9% 보너스(회사 주식 및 옵션 포함). 는 A$ 4.90M 가치에 해당하는 회사 주식의 2.6% 직접 소유합니다. 4.90M. 경영진과 이사회의 평균 재임 기간은 각각 3.4 년과 3.6 년입니다.
주요 정보
Brad O'Connor
최고 경영자
US$1.1m
총 보상
CEO 급여 비율 | 33.1% |
CEO 임기 | 18.5yrs |
CEO 소유권 | 2.6% |
경영진 평균 재임 기간 | 3.4yrs |
이사회 평균 재임 기간 | 3.6yrs |
최근 관리 업데이트
Recent updates
If EPS Growth Is Important To You, Cogstate (ASX:CGS) Presents An Opportunity
May 13The Price Is Right For Cogstate Limited (ASX:CGS)
Jan 17Is Cogstate Limited (ASX:CGS) Trading At A 29% Discount?
Jul 26Returns Are Gaining Momentum At Cogstate (ASX:CGS)
Apr 14Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%
Mar 23Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts
Mar 02Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate
Jan 13Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%
Oct 04Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?
Sep 28Returns On Capital Are A Standout For Cogstate (ASX:CGS)
Sep 02We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease
Jun 30Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital
Mar 22We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation
Oct 20Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital
Jul 23Is Cogstate (ASX:CGS) Using Too Much Debt?
Apr 29What Can The Trends At Cogstate (ASX:CGS) Tell Us About Their Returns?
Mar 14Here's What Cogstate Limited's (ASX:CGS) Shareholder Ownership Structure Looks Like
Feb 21How Much Is Cogstate's (ASX:CGS) CEO Getting Paid?
Jan 17Can You Imagine How Jubilant Cogstate's (ASX:CGS) Shareholders Feel About Its 214% Share Price Gain?
Dec 05CEO 보상 분석
날짜 | 총 보상 | 급여 | 회사 수익 |
---|---|---|---|
Dec 31 2023 | n/a | n/a | US$6m |
Sep 30 2023 | n/a | n/a | US$5m |
Jun 30 2023 | US$1m | US$363k | US$4m |
Mar 31 2023 | n/a | n/a | US$4m |
Dec 31 2022 | n/a | n/a | US$3m |
Sep 30 2022 | n/a | n/a | US$6m |
Jun 30 2022 | US$2m | US$346k | US$8m |
Mar 31 2022 | n/a | n/a | US$9m |
Dec 31 2021 | n/a | n/a | US$10m |
Sep 30 2021 | n/a | n/a | US$7m |
Jun 30 2021 | US$1m | US$344k | US$5m |
Mar 31 2021 | n/a | n/a | US$3m |
Dec 31 2020 | n/a | n/a | US$335k |
Sep 30 2020 | n/a | n/a | -US$811k |
Jun 30 2020 | US$931k | US$371k | -US$2m |
Mar 31 2020 | n/a | n/a | -US$3m |
Dec 31 2019 | n/a | n/a | -US$3m |
Sep 30 2019 | n/a | n/a | -US$3m |
Jun 30 2019 | US$655k | US$368k | -US$2m |
Mar 31 2019 | n/a | n/a | -US$2m |
Dec 31 2018 | n/a | n/a | -US$1m |
Sep 30 2018 | n/a | n/a | -US$907k |
Jun 30 2018 | US$783k | US$338k | -US$566k |
보상 대 시장: Brad 의 총 보상 ($USD 1.10M )은 Australian 시장( $USD 298.77K ).
보상과 수익: Brad 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Brad O'Connor
18.5yrs
테뉴어
US$1,098,299
보상
Mr. Bradley John O'Connor, also known as Brad, B.Bus, CA, has been the Chief Executive Officer and Managing Director of Cogstate Limited since December 1, 2005 and served as its Chief Financial Officer sin...
리더십 팀
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
CEO, MD & Executive Director | 18.5yrs | US$1.10m | 2.6% $ 5.0m | |
Founder & Chief Innovation Officer | no data | 데이터 없음 | 데이터 없음 | |
Chief Financial Officer | 3.3yrs | US$469.06k | 데이터 없음 | |
Chief Technology Officer | 3.4yrs | US$311.03k | 데이터 없음 | |
Chief Science Officer | 3.7yrs | US$421.93k | 0.029% $ 56.0k | |
Chief Commercial Officer | 4.6yrs | US$436.14k | 데이터 없음 | |
Executive VP of Clinical Trials | less than a year | US$302.28k | 0.059% $ 112.0k | |
General Counsel | 1.2yrs | 데이터 없음 | 데이터 없음 | |
Joint Company Secretary | 3.3yrs | 데이터 없음 | 데이터 없음 |
3.4yrs
평균 재임 기간
경험이 풍부한 관리: CGS 의 관리팀은 경험 ( 3.4 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
CEO, MD & Executive Director | 18.5yrs | US$1.10m | 2.6% $ 5.0m | |
General Counsel | no data | 데이터 없음 | 데이터 없음 | |
Independent Non-Executive Director | 13.8yrs | US$56.15k | 2.61% $ 5.0m | |
Non-Executive Chairman | 24.5yrs | US$94.62k | 27.18% $ 52.0m | |
Independent Non-Executive Director | 4.8yrs | US$70.97k | 0.079% $ 150.2k | |
Independent Non-Executive Director | 3.6yrs | US$64.21k | 0.0074% $ 14.1k | |
Independent Non-Executive Director | 7.4yrs | US$62.76k | 0.039% $ 75.0k | |
Member of Scientific Advisory Board | 2yrs | 데이터 없음 | 데이터 없음 | |
Distinguished Medical Adviser & Chairman of Scientific Advisory Board | 2yrs | 데이터 없음 | 데이터 없음 | |
Member of Scientific Advisory Board | 2yrs | 데이터 없음 | 데이터 없음 | |
Member of Scientific Advisory Board | 2yrs | 데이터 없음 | 데이터 없음 | |
Member of Scientific Advisory Board | 2yrs | 데이터 없음 | 데이터 없음 |
3.6yrs
평균 재임 기간
62yo
평균 연령
경험이 풍부한 이사회: CGS 의 이사회는 경험(평균 재직 기간 3.6 년)으로 간주됩니다.